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Moonlighting Proteins
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Moonlighting proteins comprise a class ofmultifunctional proteins inwhich a sin-
gle polypeptide chain has multiple biochemical functions that are not due to gene
fusion events. Examples include cytosolic enzymes that are also transcription fac-
tors, crystallins, chaperones, extracellular growth factors, or cell surface adhesins.
The variety of knownmoonlighting proteins, themultiple ways inwhich one pro-
tein can have multiple functions, the potential benefits to the organism of
combining two functions in one protein, and the methods proposed for a protein
to evolve a second function suggest thatmoonlightingproteinsmight be common.
The ability of a protein to moonlight in different multi-protein complexes or
pathways can complicate the prediction of protein function from sequence or
structure and the annotation of sequence databases. To date, most moonlighting
functions have been found by serendipity. There is currently no straightforward
method to identify which proteins moonlight, or for determining if a protein of
interest is a moonlighting protein. In addition, sequence homologues of moon-
lighting proteins often do not perform both functions. We are using biochem-
ical methods and X-ray crystallography to study individual moonlighting
proteins. We are also organizing information about the sequences, structures,
functions and functional sites of the over 200 known moonlighting proteins
into the web-based MoonProt database.
Dynamics of Ligand Binding
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Thiol Labeling Reveals Presence of Cryptic Binding Sites in b-Lactamase
Eric Bolin, Brendan Maguire, Gregory Bowman, Susan Marqusee.
University of California, Berkeley, Berkeley, CA, USA.
The field of drug design has for many years sought to design ligands for known
binding pockets in proteins. Cryptic binding sites, which are unexpected open-
ings that are invisible to normal experimental methods but can modulate activ-
ity through communication with the active site, have the ability to greatly
expand the number of proteins whose behavior and activity can be easily modu-
lated by increasing the number of druggable sites. Recent work has offered the
possibility of identifying these sites from molecular dynamics simulations of
proteins in the absence of ligands, allowing identification of sites for many li-
gands to be screened in a single experiment. To experimentally verify these
computational models, we have tested b-lactamase for the presence of cryptic
binding sites. We have employed a method using mutagenesis and thiol label-
ing to verify the transient opening of cryptic sites as well as the ability of a
large, covalent adduct at these sites to alter activity of the protein. This has
led us to conclude that conformations with transiently open pockets exist in
equilibrium with the known structure under native conditions, and these
pockets may be suitable for future drug design studies.
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Structural Dynamics Studies of Fatty Acid Binding Protein-4 by Solution
NMR Spectroscopy
Adedolapo Ojoawo, Choua Xiong, Kim N. Ha.
Chemistry and Biochemistry, St. Catherine University, St. Paul, MN, USA.
Adipocyte fatty acid binding protein-4 (FABP4) is a 132-aa intracellular lipid
binding protein involved in the transport of fatty acids between cell membranes
and organelles. FABP4 participates in several pathways including lipolysis and
lipogenesis, and is involved in lipid and energy metabolism related diseases
such as diabetes. Although the x-ray structure of FABP4 has been determined
and binding to several of its hydrophobic ligands well characterized, the tran-
sitions in the structural dynamics upon ligand binding has yet to be determined.
Here, solution NMR experiments will be carried out on 15N and 13C labeled
FABP4 to study the structural transitions between its free and bound states.
Spin relaxation measurements will also be used to reveal any changes that
occur upon binding of FABP4 to its hydrophobic ligands.
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Insights into the Cyclic Nucleotide Selectivity Mechanism of Cyclic GMP
Dependent Protein Kinase II
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Membrane bound type II cGMP dependent protein kinase (PKG II) is a central
mediator of cGMP signaling cascade, which regulates circadian rhythmicity,intestinal water secretion, bone growth and renal functions. PKG II contains
an N-terminal regulatory (R)-domain, and a C-terminal catalytic (C)-domain.
The R-domain contains tandem cyclic nucleotide binding domains (CNB-A
and B) each with different affinities for cGMP, the second messenger that reg-
ulates kinase activity of PKG II. While it is known that PKG II needs to be high-
ly selective for cGMP over cAMP to function properly, little is known about its
cyclic nucleotide selectivity and the selectivity’s role in activation. To under-
stand its cyclic nucleotide selectivity and activation mechanism of PKG II,
we first identified CNB-B to be highly selective for cGMP and solved its crystal
structure with cGMP. The complex structure revealed that PKG II utilizes an
arginine and two aspartate residues on the C-terminal helix to recognize the
guanine moiety in cGMP. This is completely different from PKG I, where a
conserved arginine from the b barrel of CNB-B specifically binds the guanine
moiety of cGMP and imparts cyclic nucleotide selectivity. We are currently
testing the roles of PKG II specific interactions in cGMP selectivity and activa-
tion of PKG II.
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Cyclophilin A is an enzyme which plays a role in the folding of proteins. It also
binds to and aids the function of the immunosuppressant drug cyclosporin A as
well as binding to the HIV-1 capsid protein.
We expand upon a method recently used in our study of HIV-1 protease and use
the computational tools FIRST and FRODA to model the flexibility and motion
of cyclophilin A in the presence and absence of its principal ligands.
In order to verify the simulation process, we have also conducted hydrogen-
deuterium exchange NMR (HDX) experiments, the results of which are also
presented.
The computational procedure is far quicker than more in-depth approaches
such as molecular dynamics, yet it yields results which are comparable with
experimental data, on a timescale of CPU-minutes.
We use the computational tools FIRST and FRODA to model the flexibility and
motion of cyclophilin A in order to predict the results of hydrogen-deuterium
exchange NMR (HDX) experiments.
The rigidity analysis software FIRST can be used to predict the "folding cores"
of proteins identified as slowly exchanging residues in HDX. This prediction is
improved using the protein mobility software FRODA.
We are using these methods to investigate the effect of ligand binding on cyclo-
philin A computationally and experimentally.
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Bridging Simulations and Calorimetry: Computational Studies of Binding
Thermodynamics and Entropy-Enthalpy Transduction
Michael K. Gilson1, Andrew T. Fenley1, Hari Muddana2.
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Molecular simulations are now fast enough that we can begin to make connec-
tions to the thermodynamic data provided by isothermal titration calorimetry.
Here, I will describe the thermodynamic analysis of a millisecond-duration pro-
tein simulation. A central result is that local perturbations of a protein, due, for
example, to binding of small molecules, may easily induce global conforma-
tional shifts with large associated shifts in entropy and enthalpy. Thus, the
global conformational shifts can effectively transduce local binding thermody-
namics into quite different overall apparent thermodynamics. This phenome-
non, which may be termed entropy-enthalpy transduction, likely occurs in
many systems, and could make measured entropies and enthalpies of binding
unreliable indicators of binding forces. Entropy-enthalpy transduction may
also help explain the high experimental variance of measured enthalpies and
entropies relative to free energies, and may underly many cases of entropy-
enthalpy compensation.
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Differential Responses of Msh2/6 and Damaged DNA Probed byMolecular
Dynamics
Freddie R. Salsbury, Jr, Lacramioara Negureanu.
Wake Forest University, Winston Salem, NC, USA.
Over the past decade, there has been a growing interest in studying the binding
of DNA to the MutSalpha protein complex. This heterodimeric protein com-
plex, the Msh2/Msh6 complex in humans, is the initial complex that can
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tion. This complex has also been shown to bind at least some types of damaged
DNA, such damages due to chemotherapeutics. We use molecular dynamics
simulations to model the changes in the protein/DNA and protein/protein inter-
faces that occur during such binding events.
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Atomic Resolution Mechanism of Cd44-Hyaluronan Protein-Carbohy-
drate Binding
Christina E. Faller1, Amanda J. Favreau2, Olgun Guvench1.
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All-atom explicit-solvent molecular dynamics simulations with advanced sam-
pling methods were applied to completely determine, at atomic resolution, the
mechanism of binding of the protein CD44 with the glycosaminoglycan carbo-
hydrate hyaluronan. The results include descriptions of: formation of the
protein-carbohydrate complex from separate protein and carbohydrate; confor-
mational switching at the binding site to enhance binding affinity; additional
binding affinity enhancement through an order-to-disorder transition in the pro-
tein; and inhibition of binding by glycosylation of CD44. These computational
results are discussed in the context of and illuminate existing experimental data.
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E,Z-farnesyl diphosphate synthase (E,Z-FPPS; Rv1068) and cis-decaprenyl
diphosphate synthase (DPPS; Rv2361c) are promising drug targets in Myco-
bacterium tuberculosis, the causative agent of tuberculosis, due to their essen-
tial roles in the early steps of isoprenoid synthesis during the bacterial cell
wall biosynthesis. In this work, we performed a series of molecular dynamics
(MD) simulations on E,Z-FPP and DPPS both free and in complex with
various ligands in order to investigate their dynamic behaviors. Binding
pocket volume calculations obtained from the MD trajectories identified
several transitions between open and closed states, indicating considerable
structural plasticity of the active sites of these proteins, with the largest flex-
ibility found with DPPS. MD simulations on the mutated E,Z-FPPS and
DPPS suggested a possible chain elongation mechanisms for the two enzymes
which work in series to synthesize the long decaprenyl diphosphate. To incor-
porate the flexibility of DPPS into our drug discovery protocol, we carried out
virtual screening of a library of 39 known DPPS inhibitors with different re-
ceptor conformers obtained from the MD simulations, finding better predic-
tive performance with several rarely sampled MD structures than with
static, X-ray crystallographic structures. Our results highlight the importance
of accounting for protein flexibility in computer-aided drug design targeting
E,Z-FPPS and DPPS.
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Study of the Dynamic and Thermodynamic Calcium Induced Transition in
the Downstream Regulatory Element Antagonist Modulator (DREAM)
using Photothermal Beam Deflection (PBD)
Walter G. Gonzalez, Jaroslava Miksovska.
Florida International University, Miami, FL, USA.
Here we show the implementation of photothermal beam deflection (PBD) as a
useful label free technique for the measurement of millisecond and sub-
millisecond kinetics. Moreover, by taking advantage of the photosensitive cal-
cium chelating compound DM-nitrophen, we have been able to photo trigger
the release of calcium and consequent binding to four DREAM constructs.
The PBD traces for photolysis of Ca2þDMNP show a fast 300 ms decay,
whereas upon addition of DREAM(65-256) an additional slow phase with a
decay of 1 ms can be resolved. Moreover, a construct lacking the first 161
amino acids shows a slower 5 ms decay.
The differences in kinetics can be corre-
lated with the oligomerization transition
associated with each construct, where
DREAM(65-256) undergoes a tetramer to
dimer and DREAM(161-256) a monomerto dimer transition upon calcium binding. Furthermore, the slow transition is
measured to be exothermic with a concomitant volume expansion. Together,
these results establish the implementation of PBD for dynamic and thermody-
namic study of calcium induced transitions in DREAM protein.
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Solid-State NMR Characterization of S31N M2 Transmembrane Domain
Bound to Novel Adamantanes with Persistent In Vitro Efficacy
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The M2 proton channel from Influenza A virus is essential for the viral life-
cycle and is an important drug target. Amino acid mutations in the residues
lining the pore of the channel have abrogated clinical efficacy of the previ-
ously FDA-approved antiviral agents, amantadine and rimantadine. More
than 95% of the circulating strains isolated from human clinical cases bear
S31N mutation and a subsequent resistance to the licensed small molecule in-
hibitors. Efforts in rational drug design targeting S31N M2 channel have been
impeded by the limited number of experimental techniques with capabilities
for structural characterization of the protein-ligand interaction in native-like
membrane mimetic environments. Solution and Solid State Nuclear Magnetic
Resonance (NMR) investigations of the recently introduced adamantane ana-
logues suggest multiple orientations of the inhibitor molecules bound in the
pore. Position of the substituent moiety in the channel varies for different
compounds, unlike the fixed orientation in the wild type channel. Here we
report a Solid State NMR investigation of the transmembrane domain of
S31N M2 (TMD) proton channel bound to the novel inhibitor molecules,
while also incorporated into a lipid bilayer environment. Oriented sample
solid state NMR experiments of S31N M2 TMD indicate that the channel is
sampling two states with helical tilts of 28 and 33 relative to the bilayer
normal. The kink in the monomer between two helical fragments, observed
in the wild type M2 TMD bound with amantadine, is absent for the S31N
M2 TMD bound to all inhibitor molecules tested to date. Stabilizing interac-
tions are further investigated with Rotational Echo Double Resonance Magic
Angle Spinning (REDOR MAS) experiments for measuring distances from
the inhibitor to the protein.
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The NMDA receptor is one class of ionotropic glutamate receptors, which are
the primary mediators of excitatory neurotransmission in the central nervous
system. As such, function and dysfunction of these receptors has been impli-
cated in such physiological and pathological processes as learning and mem-
ory, strokes, Alzheimer disease, and Parkinson disease. Studies into the
similarly structured AMPA-type glutamate receptor have revealed a relation-
ship between the extent of closure of the agonist-binding domain cleft and acti-
vation of the channel, showing a structural mechanism for transduction of
signal from binding of ligand to receptor activation. However, neither crystal
structures nor more dynamics-based studies using ensemble FRET/LRET
show such a correlation when examining the agonist-binding domain of the
glycine-binding subunit of the NMDA receptor. Here, we use single molecule
FRET to examine more closely the range of conformation states probed by the
isolated agonist-binding domain. To perform this, we had to overcome the
problem of immutable native cysteines, which resulted in non-specific labeling
when using the conventional maleimide-conjugated fluorophores that are regu-
larly used in protein-based FRET studies. Thus, we introduced the unnatural
amino acid p-acetylphenylalanine, which contains a unique ketone functional
group, at the sites which we wished to test, allowing for specific labeling of the
protein. Doing this, we see that while the protein exhibits a peak probability
around 33A˚ when bound both to full agonist glycine and partial agonist
ACPC, the protein bound to partial agonist probes a slightly broader range
of states than full agonist. From these data, we can infer that while the
agonist-binding domain may show similar average extents of cleft closure,
irresolvable by crystallography or ensemble LRET, full agonists more
narrowly restrict the range of conformational states probed to conformations
that allow for channel activation.
